NDC 42799-816-01 8 fl oz (237 mL) bottle Dispense in tight, light-resistant glass or PET plastic containers as defined in the USP
41 Many factors that normally stimulate ET-1 synthesis, (for example, thrombin and AT-II) also cause the release of vasodilators, such as prostacyclin (PGI 2 ) and/or NO, which oppose the vasoconstricting function of ET-1
Novel targets with potential to improve gastric motor functions include the pylorus, macrophage/inflammatory function, oxidative stress, and neurogenesis
Centers with dedicated endometriosis specialists and multidisciplinary teams demonstrate shorter diagnostic times compared to general gynecology practices
Review Methodology and Evidence Standards Applied The evaluation in this article is based on the following sources: the official ProHealth product page at prohealth.com, the Supplement Facts label as published (REV.04.25), the brand's published FAQ and company background materials, published research cited on the product page, and publicly available scientific literature on BPC-157's regulatory and research status